{"id":"W4416018995","doi":"10.1016/j.ijgc.2025.102238","title":"FIRST-LINE LENVATINIB + PEMBROLIZUMAB VERSUS CHEMOTHERAPY FOR ADVANCED OR RECURRENT ENDOMETRIAL CANCER: ADDITIONAL 1-YEAR FOLLOW-UP RESULTS FROM ENGOT-EN9/LEAP-001","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Lenvatinib; Chemotherapy; MEDLINE; Compassionate Use","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002747835,0.0009789892,0.002350898,0.0004442281,0.000468665,0.001199564,0.0007832196,0.001268058,0.003222472],"category_scores_gemma":[0.001865626,0.0003907525,0.003758439,0.0005340407,0.0004740913,0.00144268,0.0004823747,0.002764452,0.0007509495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001254493,"about_ca_system_score_gemma":0.00102344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002771924,"about_ca_topic_score_gemma":0.005582757,"domain_scores_codex":[0.9987662,0.0004499004,0.00007717218,0.0002768274,0.0001174031,0.0003125506],"domain_scores_gemma":[0.9983684,0.0003824039,0.0003922395,0.0002538546,0.00009129219,0.0005117593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8460257,0.01746459,0.03924637,0.0005431566,0.0086574,0.0002817198,0.0001646352,0.002468738,0.005729594,0.0001210441,0.002898165,0.0763988],"study_design_scores_gemma":[0.1930769,0.3404435,0.4369843,0.0002328488,0.01532985,0.0006549636,0.0003312326,0.00316542,0.002979107,0.0005202931,0.006165884,0.0001157811],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914795,0.003311951,0.0002361311,0.0002854482,0.0001294837,0.0002395385,0.003028049,0.00003506476,0.001254787],"genre_scores_gemma":[0.9848016,0.00213158,0.0005419948,0.0008964051,0.0001926109,0.0003255954,0.008458015,0.00002474057,0.002627369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003222472,"threshold_uncertainty_score":0.01453209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09522776136698008,"score_gpt":0.4334918706970344,"score_spread":0.3382641093300544,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}